(Q50770109)
Statements
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer (English)
Robert M Sharkey
George Hajjar
Dion Yeldell
Arnold Brenner
Jack Burton
Arnold Rubin
David M Goldenberg